Cook TJ - Search Results

1

Plasma homocysteine concentration, statin therapy, and the risk of first acute coronary events.

Ridker PM, Shih J, Cook TJ, Clearfield M, Downs JR, Pradhan AD, Weis SE, Gotto AM Jr; Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) Investigators. Ridker PM, et al. Among authors: cook tj. Circulation. 2002 Apr 16;105(15):1776-9. Circulation. 2002. PMID: 11956118 Clinical Trial.

2

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.

Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, Seshasai SR, McMurray JJ, Freeman DJ, Jukema JW, Macfarlane PW, Packard CJ, Stott DJ, Westendorp RG, Shepherd J, Davis BR, Pressel SL, Marchioli R, Marfisi RM, Maggioni AP, Tavazzi L, Tognoni G, Kjekshus J, Pedersen TR, Cook TJ, Gotto AM, Clearfield MB, Downs JR, Nakamura H, Ohashi Y, Mizuno K, Ray KK, Ford I. Sattar N, et al. Among authors: cook tj. Lancet. 2010 Feb 27;375(9716):735-42. doi: 10.1016/S0140-6736(09)61965-6. Epub 2010 Feb 16. Lancet. 2010. PMID: 20167359

3

Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S.

Ballantyne CM, Olsson AG, Cook TJ, Mercuri MF, Pedersen TR, Kjekshus J. Ballantyne CM, et al. Among authors: cook tj. Circulation. 2001 Dec 18;104(25):3046-51. doi: 10.1161/hc5001.100624. Circulation. 2001. PMID: 11748098 Clinical Trial.

4

Effects of cigarette smoking on the angiographic evolution of coronary atherosclerosis. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy. CCAIT Study Group.

Waters D, Lespérance J, Gladstone P, Boccuzzi SJ, Cook T, Hudgin R, Krip G, Higginson L. Waters D, et al. Circulation. 1996 Aug 15;94(4):614-21. doi: 10.1161/01.cir.94.4.614. Circulation. 1996. PMID: 8772679 Clinical Trial.

5

Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S).

Pedersen TR, Olsson AG, Faergeman O, Kjekshus J, Wedel H, Berg K, Wilhelmsen L, Haghfelt T, Thorgeirsson G, Pyörälä K, Miettinen T, Christophersen B, Tobert JA, Musliner TA, Cook TJ. Pedersen TR, et al. Among authors: cook tj. Circulation. 1998 Apr 21;97(15):1453-60. doi: 10.1161/01.cir.97.15.1453. Circulation. 1998. PMID: 9576425 Clinical Trial.

6

Effects of cholesterol lowering on the progression of coronary atherosclerosis in women. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) substudy.

Waters D, Higginson L, Gladstone P, Boccuzzi SJ, Cook T, Lespérance J. Waters D, et al. Circulation. 1995 Nov 1;92(9):2404-10. doi: 10.1161/01.cir.92.9.2404. Circulation. 1995. PMID: 7586338 Clinical Trial.

7

Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S).

Miettinen TA, Pyörälä K, Olsson AG, Musliner TA, Cook TJ, Faergeman O, Berg K, Pedersen T, Kjekshus J. Miettinen TA, et al. Among authors: cook tj. Circulation. 1997 Dec 16;96(12):4211-8. doi: 10.1161/01.cir.96.12.4211. Circulation. 1997. PMID: 9416884 Clinical Trial.

8

Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study.

Haffner SM, Alexander CM, Cook TJ, Boccuzzi SJ, Musliner TA, Pedersen TR, Kjekshus J, Pyörälä K. Haffner SM, et al. Among authors: cook tj. Arch Intern Med. 1999 Dec 13-27;159(22):2661-7. doi: 10.1001/archinte.159.22.2661. Arch Intern Med. 1999. PMID: 10597756 Clinical Trial.

9

Simvastatin for secondary prevention of all-cause mortality and major coronary events in patients with mild chronic renal insufficiency.

Chonchol M, Cook T, Kjekshus J, Pedersen TR, Lindenfeld J. Chonchol M, et al. Am J Kidney Dis. 2007 Mar;49(3):373-82. doi: 10.1053/j.ajkd.2006.11.043. Am J Kidney Dis. 2007. PMID: 17336698 Clinical Trial.

10

Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatment.

Wilhelmsen L, Pyörälä K, Wedel H, Cook T, Pedersen T, Kjekshus J. Wilhelmsen L, et al. Eur Heart J. 2001 Jul;22(13):1119-27. doi: 10.1053/euhj.2000.2481. Eur Heart J. 2001. PMID: 11428852 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

111 results

Search Page